Home
About
Publications Trends
Recent Publications
Expert Search
Archive
growth factors
Which Growth Factors Are Commonly Involved in Cancer?
Several growth factors and their receptors are commonly associated with cancers:
Epidermal Growth Factor (EGF)
: Often implicated in cancers of the breast, lung, and colon.
Vascular Endothelial Growth Factor (VEGF)
: Plays a significant role in angiogenesis, the formation of new blood vessels, which is crucial for tumor growth and metastasis.
Platelet-Derived Growth Factor (PDGF)
: Frequently involved in gliomas and other cancers.
Transforming Growth Factor-beta (TGF-beta)
: Has dual roles, acting as a tumor suppressor in normal cells but promoting tumor progression in advanced cancers.
Frequently asked queries:
How Do Growth Factors Contribute to Cancer?
Which Growth Factors Are Commonly Involved in Cancer?
What is λ?
How Can Patients Ensure They Are Billed Correctly?
What Can Be Done to Mitigate Long-Term Impacts?
What is the Future of Drug Delivery in Cancer Treatment?
Who Can Participate in the Trial?
What Causes CINV?
What is Margarine?
What is the Role of Nutritionists in Cancer Care?
How Does Breath Focus Benefit Cancer Patients?
What Are the Challenges in Controlling Proliferation?
What are the Risks of Using Warfarin in Cancer Patients?
How Can Technology Enhance Leadership in Cancer Care?
What are the Challenges of Conducting Prevention Trials?
What infections are associated with increased cancer risk?
Are There Alternatives to Esophageal Dilation?
Why is Anonymization Important in Cancer Research?
Can Progenitor Cells Be Used in Cancer Treatment?
What is the Impact of Personalized Medicine?
Follow Us
Facebook
Linkedin
Youtube
Instagram
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Nanotechnology
Non-Hodgkin’s Lymphoma
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
CIAbimatoprost
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
diffuse large B-cell lymphoma
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
Keratinocyte
Lipid-based nanoparticles
liver cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
radiotherapy
refractory lymphoma
relapsed lymphoma
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe